Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News Analysis
Nature Reviews Drug Discovery 6, 770–771 (1 October 2007) | doi:10.1038/nrd2434
Steps on the road to personalized medicine
Abstract
The incorporation of information on genetic testing into the product label of the anticoagulant warfarin and the FDA marketing clearance for an associated test represent a significant advance for the field of pharmacogenetics.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
